LAUSR

prevention of diverticulitis: a systematic review of randomized clinical trials. J Clin Gastroenterol. 2016;50(suppl 1): S64–S69. 2. Humes DJ, Fleming KM, Spiller RC, et al. Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study. Gut. 2011;60:219–224. 3. Khan MA, Ali B, Lee WM, et al. Mesalamine does not help prevent recurrent acute colonic diverticulitis: meta-analysis of randomized, placebo-controlled Trials. Am J Gastroenterol. 2016;111:579–581. 4. Bassotti G, Battaglia E, De Roberto G, et al. Alterations in colonic motility and relationship to pain in colonic diverticulosis. Clin Gastroenterol Hepatol. 2005; 3:248–253. 5. Simpson J, Neal KR, Scholefield JH, et al. Patterns of pain in diverticular disease and the influence of acute diverticulitis. Eur J Gastroenterol Hepatol. 2003;15:1005–1010. 6. Bassotti G, Battaglia E, Bellone G, et al. Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. J Clin Pathol. 2005;58:973–977. 7. Simpson J, Sundler F, Humes DJ, et al. Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil. 2009;21:e847–e858.